Mark Vignola, Ph.D., was the Chief Financial Officer at Terns Pharmaceuticals, a biopharmaceutical company with a market capitalization of $397 million.
Mark Vignola, Ph.D., was the Chief Financial Officer at Terns Pharmaceuticals, a biopharmaceutical company with a market capitalization of $397 million. He departed his role on February 1, 2025, in line with a transition agreement. Following his departure, he entered into a consulting agreement with Terns Pharmaceuticals through July 31, 2025, receiving a monthly fee for his services.
Full founder directory · Investor directory · Company funding database · Fundraising library